Cincinnati, OHNCT06927999Now EnrollingIRB Ready

Urticaria Chronic Clinical Trial in Cincinnati, OH

Access cutting-edge urticaria chronic treatment through this phase 2 clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.

Sponsored by ARS Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this Cincinnati location

Preparing your pre-screening questions…

Expert Care in Cincinnati

Access urticaria chronic specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related urticaria chronic treatment provided free

Apply for This Cincinnati Location

Check if you qualify for this urticaria chronic clinical trial in Cincinnati, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cincinnati

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cincinnati site if eligible
  4. 4Begin participation

About This Urticaria Chronic Study in Cincinnati

This is a Phase 2b, outpatient, single-dose, randomized, double blind, placebo-controlled, three period crossover study that will consist of a screening period and three blinded treatment periods. Subjects enrolled will have CSU with a history of moderate to severe acute exacerbations (or flares).

Sponsor: ARS Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Is a male or female between the ages of 18 and 65 years, inclusive.
Has been clinically diagnosed with CSU and experiences an acute flare of moderate to severe urticaria symptoms (itch and hive severity UAS score ≥ 2) approximately 1-2 times a month or every other month consistently during the past year while on a chronic treatment.
Has been on a daily chronic treatment for ≥ 6 weeks.
Is willing to use a smartphone study application to record study assessments and AEs.
Has body weight more than 15 kilogram (kg).
Has no medical history of clinically significant hypertension and cardiovascular disease in the last 10 years
If female, is not pregnant or breastfeeding based on a negative urine pregnancy test at baseline.
Is able to communicate clearly with the Investigator and staff; able to read, complete questionnaires, and perform study procedures on the smartphone study application.
Is willing and able to provide written informed consent prior to participating in the study.
Controlled hypertension without beta blocker confirmed by the Investigator is acceptable.
At screening, has stable vital signs in the following ranges (after 5 minutes of rest):
Systolic blood pressure (SBP) ≥90 and ≤140 milliliters of mercury (mmHg)
Diastolic blood pressure (DBP) ≥50 and ≤90 mmHg
Heart rate (HR) ≥45 and ≤100 beats per minute (bpm)

Exclusion Criteria

Has a history of clinically significant gastrointestinal, renal, hepatic, neurologic, hematologic, endocrine, oncologic, pulmonary, immunologic, psychiatric, or cardiovascular disease or any other condition which, in the opinion of the Investigator, would jeopardize the safety of the subject or impact the validity of the study results.
Has any clinically significant medical condition or PE finding as deemed inappropriate by the Investigator.
Has abnormal cardiovascular exam at screening including any prior history of myocardial infarction or clinically significant abnormal electrocardiogram (ECG)
Has had significant traumatic injury or major surgery within 30 days prior to study screening.
Known hypersensitivity to any compound in the test product, or any other closely related compound (e.g., dihydropyridine-derived molecules).
Has participated in a clinical trial within 30 days prior to the first dose of study drug.
Has an immediate family member of the Investigator, or an employee of the study center, with direct involvement in the proposed study, or other studies under the direction of the Investigator or study center or is in a dependent relationship with a study center employee who is involved in the conduct of this study (e.g., spouse, parent, child, sibling), or may consent under duress.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cincinnati?

Yes, this clinical trial (NCT06927999) has an active research site in Cincinnati, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Urticaria Chronic Treatment Options in Cincinnati, OH

If you're searching for urticaria chronic treatment options in Cincinnati, OH, this clinical trial (NCT06927999) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cincinnati research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced urticaria chronic specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all urticaria chronic clinical trials near you to find additional studies recruiting in your area.

More Chronic Urticaria Trials in Cincinnati, OH

See all chronic urticaria clinical trials recruiting in Cincinnati — not just this study.

Browse Chronic Urticaria Trials in Cincinnati →

Browse More Trials by Condition

Chronic Urticaria TrialsInterstitial Cystitis TrialsUrticaria TrialsAll Conditions →

Ready to Join in Cincinnati?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cincinnati, OH